Cellebrite DI (CLBT) Invested Capital (2020 - 2025)

Cellebrite DI (CLBT) has reported Invested Capital for 6 consecutive years, with $484.3 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Invested Capital rose 44.13% year-over-year to $484.3 million; the TTM figure through Dec 2025 stood at $484.3 million (up 44.13% YoY), while the FY2025 annual figure was $484.3 million, up 44.13% from the prior year.
• Invested Capital came in at $484.3 million for Q4 2025 at Cellebrite DI, up from $447.7 million in the prior quarter.
• The five-year high for Invested Capital was $484.3 million in Q4 2025, with the low at -$130.0 million in Q3 2021.
• Average Invested Capital over 5 years is $130.1 million, with a median of $38.6 million recorded in 2023.
• Across the five-year window, Invested Capital sank 328.75% in 2024 and jumped 1461.09% in 2025, its largest moves.
• Year by year, Invested Capital stood at -$73.3 million in 2021, then jumped by 200.71% to $73.9 million in 2022, then slumped by 53.68% to $34.2 million in 2023, then soared by 882.17% to $336.0 million in 2024, then soared by 44.13% to $484.3 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $484.3 million, $447.7 million, and $408.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.